Fig. 1 · Structure

Documents & Downloads

Rheochrysidin (Physcione)

Cat. No. A10787 CAS 521-61-9
Rheochrysidin is one of the major components of Da-Cheng-Qi decoction used in the treatment of inflammation.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Cellular Effect

Cell Line Activity Value Description Reference
A549 IC50 > 100 μg/mL Antiproliferative activity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay [PMID: 26995526]
A549 IC50 1.5 μM Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 72 hrs by sulforhodamine B assay [PMID: 33691166]
HCT-116 IC50 19 μM Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay [PMID: 17949858]
HepG2 IC50 77.3 μM Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay [PMID: 17949858]
HT-29 IC50 > 100 μg/mL Antiproliferative activity against human HT-29 cells assessed as growth inhibition after 48 hrs by MTT assay [PMID: 26995526]
HUVEC IC50 > 100 μg/mL Antiproliferative activity against human HUVEC cells assessed as growth inhibition after 48 hrs by MTT assay [PMID: 26995526]
MCF7 IC50 > 100 μg/mL Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 48 hrs by MTT assay [PMID: 26995526]
NCI-H157 IC50 3 μM Antiproliferative activity against human NCI-H157 cells assessed as reduction in cell viability measured after 72 hrs by sulforhodamine B assay [PMID: 33691166]

Rheochrysidin (Physcione) Research Summary

This section summarizes 2 in vivo studies of Rheochrysidin (Physcione) from 2 published references.

Rheochrysidin (Physcione) In Vivo Studies

The Rheochrysidin records describe rat cerebral ischemia reperfusion studies, with treatment reported as physcion. Daily oral gavage after I/R decreased infarct area compared with the I/R group following middle cerebral artery occlusion. In the other study, intragastric treatment before model establishment was associated with a lower neurological function score than the model group. [1,2]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Treatment effects on cerebral infarction in rats

Animal study · SD rats (8 weeks old); Middle cerebral artery occlusion (MCAO); n = 18 per group; brain tissues (n = 6 per group) [1]

In SD rats subjected to middle cerebral artery occlusion, physcion was administered daily by oral gavage after I/R. Treatment decreased infarct area compared with the I/R group, as assessed by TTC staining.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
TTC staining was applied to assess infarct areaReported result Physcion (20 or 40 mg/kg) via oral gavage after I/R every day: physcion treatment obviously decreased areas of infarction compared to I/R group.[1]

Conditions shared by the study groups

Route
oral gavage
Treatment course
after I/R every day
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Rheochrysidin 20 or 40 mg/kgI/R groupPhyscion (20 or 40 mg/kg) via oral gavage after I/R every day: physcion treatment obviously decreased areas of infarction compared to I/R group.[1]
Rheochrysidin 20 or 40 mg/kg
Model: SD rats (8 weeks old); Middle cerebral artery occlusion (MCAO); n = 18 per group; brain tissues (n = 6 per group)
Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: Rheochrysidin; Compound label in the paper: Physcion

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Materials and Methods > Animal Study (S22, S23, S27, S28); Materials and Methods > Triphenyltetrazolium Chloride (TTC) Staining (S33); Results > Physcion Protects Rats Against Brain Damage After I/R via Inhibiting the TLR4/NF-κB Pathway (S75); Figure 5 legend (S99)

TTC staining was applied to assess infarct area: TTC staining was applied to assess infarct area; comparator: I/R group — Materials and Methods > Animal Study (S28); Results > Physcion Protects Rats Against Brain Damage After I/R via Inhibiting the TLR4/NF-κB Pathway (S75); Figure 5 legend (S99)

Rheochrysidin 20 or 40 mg/kg · Materials and Methods > Animal Study (S28); Results > Physcion Protects Rats Against Brain Damage After I/R via Inhibiting the TLR4/NF-κB Pathway (S75)

Neurological function scores in cerebral ischemia reperfusion rats

Animal study · Male Sprague-Dawley (SD) Rats; cerebral ischemia reperfusion; n = 10 each [2]

Male Sprague-Dawley rats received intragastric treatment before establishment of a cerebral ischemia reperfusion model. The physcion group had a lower neurological function score than the model group.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Neurological Function ScoreReported result Physcion 26.4 mg/kg: 2.56 ± 1.13; Model group: 3.11 ± 0.78[2]

Conditions shared by the study groups

Route
intragastrically
Treatment course
once a day for seven consecutive days; a cerebral apoplexy reperfusion model was established 2 h after the last administration
Vehicle
0.5%CMC-Na
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Rheochrysidin 26.4 mg/kgModel groupPhyscion 26.4 mg/kg: 2.56 ± 1.13; Model group: 3.11 ± 0.78[2]
Rheochrysidin 26.4 mg/kg
Model: Male Sprague-Dawley (SD) Rats; cerebral ischemia reperfusion; n = 10 each
Reported limits: Removed after verification: value.
Methods and source locations

Compound reported in the paper: Rheochrysidin; Compound label in the paper: Physcion

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

4. Materials and Methods > 4.1. Material > 4.1.2. Animals and Cerebral Ischemia Reperfusion Model in Rats (S23, S27); 4. Materials and Methods > 4.2. Pharmacodynamic Study of Anticerebral Ischemia-Reperfusion Injury > 4.2.1. Grouping and Administration (S34, S35, S36, S38, S39, S40); Table 1 (T1.h1, T1.r2, T1.r8)

Neurological Function Score: Neurological Function Score; comparator: Model group — 4. Materials and Methods > 4.2. Pharmacodynamic Study of Anticerebral Ischemia-Reperfusion Injury > 4.2.1. Grouping and Administration (S35); Table 1 (T1.h1, T1.r2, T1.r8)

Rheochrysidin 26.4 mg/kg · 4. Materials and Methods > 4.2. Pharmacodynamic Study of Anticerebral Ischemia-Reperfusion Injury > 4.2.1. Grouping and Administration (S35, S39, S40); Table 1 (T1.r2, T1.r8)

Specifications

Manufacturer Adooq Bioscience
CAS Number 521-61-9
Formula C16H12O5
Molecular Weight 284.3
Synonyms Physcion; Physcione; Parietin; Emodin 3-methyl ether; NSC 251670
SMILES
CC1=CC(=C2C(=C1)C(=O)C3=CC(=CC(=C3C2=O)O)OC)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO Warmed: 1 mg/mL (3.51 mM)
Water Insoluble
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Rheochrysidin (Physcione) Research References

  1. [1] Dong X, Wang L, Song G, et al. Physcion Protects Rats Against Cerebral Ischemia-Reperfusion Injury via Inhibition of TLR4/NF-kB Signaling Pathway. Drug Des Devel Ther (2021). PMID: 33536742 DOI: 10.2147/DDDT.S267856 Source material
  2. [2] Li RR, Liu XF, Feng SX, et al. Pharmacodynamics of Five Anthraquinones (Aloe-emodin, Emodin, Rhein, Chysophanol, and Physcion) and Reciprocal Pharmacokinetic Interaction in Rats with Cerebral Ischemia. Molecules (2019). PMID: 31108858 DOI: 10.3390/molecules24101898 Source material

Added to your cart

View Cart Checkout
Loading...